Lime Therapeutics
New York, US · Founded 2021 · 6 employees on LinkedIn · 2 known investors
Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
Founders & leadership
Lime Therapeutics was founded in 2021 by Prakrit V. Jena.
PV
Prakrit V. JenaCo-founder & CTO
SS
Shardule ShahCEO
Investors · 2
Frequently asked questions
- What does Lime Therapeutics do?
- Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
- Who founded Lime Therapeutics?
- Lime Therapeutics was founded by Prakrit V. Jena in 2021.
- Who are Lime Therapeutics's investors?
- Lime Therapeutics's investors include HBS Angels of Boston, ZAKA VC.
- Where is Lime Therapeutics headquartered?
- Lime Therapeutics is headquartered in New York, US.